# OnCo record lee-dae-ho (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/lee-dae-ho/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "lee-dae-ho" ;
  schema:name "Dae Ho Lee"@en ;
  schema:description "Dae Ho Lee is a thoracic oncologist behind Korean participation in the EGFR, ALK, and MET inhibitor trials that shaped lung cancer care."@en ;
  schema:url <https://onco.cc/people/lee-dae-ho/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:citation <https://eng.amc.seoul.kr>, <https://pubmed.ncbi.nlm.nih.gov/?term=Lee%20DH%5BAuthor%5D%20Asan%20lung%20cancer> ;
  schema:jobTitle "Professor of Medical Oncology; thoracic oncology" ;
  onco:cancers <https://onco.cc/cancers/nsclc/> ;
  onco:targets <https://onco.cc/targets/egfr/>, <https://onco.cc/targets/met/> ;
  onco:drugs <https://onco.cc/drugs/amivantamab/>, <https://onco.cc/drugs/lazertinib/>, <https://onco.cc/drugs/osimertinib/> ;
  onco:institutions <https://onco.cc/institutions/asan-medical-center/> ;
  onco:trials <https://onco.cc/trials/mariposa/> ;
  schema:affiliation <https://onco.cc/institutions/asan-medical-center/> .